Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential
- 1 April 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (4) , 541-546
- https://doi.org/10.1038/modpathol.3800321
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Is atypical follicular adenoma of the thyroid a preinvasive malignancy?Human Pathology, 2003
- Distinction Between Papillary Thyroid Hyperplasia and Papillary Thyroid Carcinoma by Immunohistochemical Staining for Cytokeratin 19, Galectin-3, and HBME-1Endocrine Pathology, 2003
- Observer Variation of Encapsulated Follicular Lesions of the Thyroid GlandThe American Journal of Surgical Pathology, 2002
- Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinomaActa Endocrinologica, 2002
- Reduced HBME‐1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma‐related neoplastic lesions with Hürthle cell and/or apocrine‐like changesHistopathology, 2002
- Follicular, Papillary, and "Hybrid" Carcinomas of the ThyroidEndocrine Pathology, 2002
- Galectin-3 as a Presurgical Immunocytodiagnostic Marker of Minimally Invasive Follicular Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2001
- Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesionsThe Lancet, 2001
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- Guest Editorial: Two Proposals Regarding the Terminology of Thyroid TumorsInternational Journal of Surgical Pathology, 2000